Citizens National Bank Trust Department’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78K Hold
200
0.01% 241
2026
Q1
$94.6K Hold
200
0.02% 228
2025
Q4
$93.4K Hold
200
0.02% 216
2025
Q3
$85.2K Hold
200
0.02% 217
2025
Q2
$76.6K Hold
200
0.02% 217
2025
Q1
$69.1K Hold
200
0.01% 225
2024
Q4
$60K Hold
200
0.01% 218
2024
Q3
$81.3K Hold
200
0.02% 202
2024
Q2
$64.3K Hold
200
0.01% 208
2024
Q1
$66.7K Hold
200
0.02% 205
2023
Q4
$54.1K Hold
200
0.01% 207
2023
Q3
$49.2K Hold
200
0.01% 207
2023
Q2
$60.7K Hold
200
0.02% 199
2023
Q1
$52.7K Hold
200
0.01% 200
2022
Q4
$48K Hold
200
0.01% 203
2022
Q3
$37K Hold
200
0.01% 212
2022
Q2
$34K Hold
200
0.01% 222
2022
Q1
$43K Hold
200
0.02% 197
2021
Q4
$51K Buy
+200
New +$48.9K 0.02% 192

Other funds holding HCA

Citizens National Bank Trust Department's HCA Position: Q2 2026 in Review

Citizens National Bank Trust Department held its HCA Healthcare (HCA) position steady in Q2 2026 at 200 shares worth $78K. The position accounts for 0.01% of the portfolio, ranked #241.

Citizens National Bank Trust Department first reported a position in HCA in Q4 2021 and has held it in 19 quarters since. The position peaked at $94.6K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Citizens National Bank Trust Department held 200 shares of HCA Healthcare worth $78K as of Q2 2026.
  • Citizens National Bank Trust Department left its HCA Healthcare share count unchanged in Q2 2026.
  • HCA Healthcare made up 0.01% of Citizens National Bank Trust Department's portfolio in Q2 2026, its #241 holding.
  • Citizens National Bank Trust Department first reported a position in HCA Healthcare in Q4 2021 and has held it in 19 quarters since.
  • Citizens National Bank Trust Department's HCA Healthcare position peaked at $94.6K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Citizens National Bank Trust Department's 13F filing for Q2 2026, filed 22 Jul 2026.